These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 17012048)
1. Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer. Kwock L; Smith JK; Castillo M; Ewend MG; Collichio F; Morris DE; Bouldin TW; Cush S Lancet Oncol; 2006 Oct; 7(10):859-68. PubMed ID: 17012048 [TBL] [Abstract][Full Text] [Related]
2. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Parivar F; Hricak H; Shinohara K; Kurhanewicz J; Vigneron DB; Nelson SJ; Carroll PR Urology; 1996 Oct; 48(4):594-9. PubMed ID: 8886066 [TBL] [Abstract][Full Text] [Related]
3. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging. Coakley FV; Chen I; Qayyum A; Westphalen AC; Carroll PR; Hricak H; Chen MH; Kurhanewicz J BJU Int; 2007 Jan; 99(1):41-5. PubMed ID: 17227490 [TBL] [Abstract][Full Text] [Related]
4. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T. Lagemaat MW; Zechmann CM; Fütterer JJ; Weiland E; Lu J; Villeirs GM; Holshouser BA; van Hecke P; Lemort M; Schlemmer HP; Barentsz JO; Roell SO; Heerschap A; Scheenen TW J Magn Reson Imaging; 2012 Jan; 35(1):166-73. PubMed ID: 21960013 [TBL] [Abstract][Full Text] [Related]
5. Spectroscopy in prostate cancer: hope or hype? Roach M; Kurhanewicz J; Carroll P Oncology (Williston Park); 2001 Nov; 15(11):1399-410; discussion 1415-6, 1418. PubMed ID: 11758871 [TBL] [Abstract][Full Text] [Related]
6. Mapping of prostate cancer by 1H MRSI. Kobus T; Wright AJ; Scheenen TW; Heerschap A NMR Biomed; 2014 Jan; 27(1):39-52. PubMed ID: 23761200 [TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy imaging in the study of human brain cancer. Martínez-Bisbal MC; Celda B Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):618-30. PubMed ID: 20016453 [TBL] [Abstract][Full Text] [Related]
9. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy. Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer. Huzjan R; Sala E; Hricak H Nat Clin Pract Urol; 2005 Sep; 2(9):434-42. PubMed ID: 16474681 [TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopic imaging in brain tumor diagnosis. Gruber S; Stadlbauer A; Mlynarik V; Gatterbauer B; Roessler K; Moser E Neurosurg Clin N Am; 2005 Jan; 16(1):101-14, vi. PubMed ID: 15561531 [TBL] [Abstract][Full Text] [Related]
12. Improving proton MR spectroscopy of brain tissue for noninvasive diagnostics. Alusta P; Im I; Pearce BA; Beger RD; Kretzer RM; Buzatu DA; Wilkes JG J Magn Reson Imaging; 2010 Oct; 32(4):818-29. PubMed ID: 20882612 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging. Costouros NG; Coakley FV; Westphalen AC; Qayyum A; Yeh BM; Joe BN; Kurhanewicz J AJR Am J Roentgenol; 2007 Mar; 188(3):812-6. PubMed ID: 17312072 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopy in clinical oncology. Golder W Onkologie; 2004 Jun; 27(3):304-9. PubMed ID: 15249722 [TBL] [Abstract][Full Text] [Related]
15. Automated vs. manual pattern recognition of 3D (1)H MRSI data of patients with prostate cancer. Zechmann CM; Menze BH; Kelm BM; Zamecnik P; Ikinger U; Giesel FL; Thieke C; Delorme S; Hamprecht FA; Bachert P Acad Radiol; 2012 Jun; 19(6):675-84. PubMed ID: 22578226 [TBL] [Abstract][Full Text] [Related]
16. Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging. Casciani E; Gualdi GF Abdom Imaging; 2006; 31(4):490-9. PubMed ID: 16955379 [TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer. Nayyar R; Kumar R; Kumar V; Jagannathan NR; Gupta NP; Hemal AK BJU Int; 2009 Jun; 103(12):1614-20. PubMed ID: 19338548 [TBL] [Abstract][Full Text] [Related]
18. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate. Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729 [TBL] [Abstract][Full Text] [Related]
19. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. Shukla-Dave A; Hricak H; Kattan MW; Pucar D; Kuroiwa K; Chen HN; Spector J; Koutcher JA; Zakian KL; Scardino PT BJU Int; 2007 Apr; 99(4):786-93. PubMed ID: 17223922 [TBL] [Abstract][Full Text] [Related]